HLA-ABC Antikörper (PE)
-
- Target Alle HLA-ABC Antikörper anzeigen
- HLA-ABC
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-ABC Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Verwendungszweck
- Mouse monoclonal antibody raised against native HLA-Class I.
- Spezifität
- This antibody reacts with all human classical MHC Class I molecules in native cell-surface forms (e.g. it recognizes native HLA-A2 in cytofluorometry and immunoprecipitation but not in Western blot). This antibody is positive in Western blot (non-reducing conditions) only with most HLA-B and HLA-C molecules, but not HLA-A.
- Immunogen
- Native purified HLA-Class I from PHA-activated peripheral blood lymphocytes.
- Klon
- MEM-147
- Isotyp
- IgG1
- Top Product
- Discover our top product HLA-ABC Primärantikörper
-
-
- Applikationshinweise
-
Flow Cytometry (5 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.1 mg/mL
- Buffer
- In PBS (0.2 % BSA, 0.09 % sodium azide)
- Lagerung
- 4 °C
- Informationen zur Lagerung
-
Store in the dark at 4°C. Do not freeze.
Avoid prolonged exposure to light.
Aliquot to avoid repeated freezing and thawing.
-
-
Expression of HLA-G in human cornea, an immune-privileged tissue." in: Human immunology, Vol. 64, Issue 11, pp. 1039-44, (2003) (PubMed).
: "The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex." in: Immunogenetics, Vol. 53, Issue 6, pp. 440-6, (2001) (PubMed).
: "
-
Expression of HLA-G in human cornea, an immune-privileged tissue." in: Human immunology, Vol. 64, Issue 11, pp. 1039-44, (2003) (PubMed).
-
- Target
- HLA-ABC
- Andere Bezeichnung
- HLA Class I ABC (HLA-ABC Produkte)
- Synonyme
- HLAA antikoerper, major histocompatibility complex, class I, A antikoerper, HLA-A antikoerper
- Pathways
- T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-